Why the study?
Does quantitative contrast-enhanced CMR measuring LGE improve the assessment of SCD event risk in patients with hypertrophic cardiomyopathy?
Does quantitative contrast-enhanced CMR measuring LGE improve the assessment of SCD event risk in patients with hypertrophic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
Extensive LGE on CMR helps stratify sudden cardiac death risk in HCM patients, especially those otherwise considered low risk.
Extensive LGE measured by quantitative contrast enhanced CMR provides additional information for assessing SCD event risk among HCM patients, particularly patients otherwise judged to be at low risk.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: